Date of Revision s2

MATERIAL SAFETY DATA SHEET Pharmacal Research Laboratories Inc.  33 Great Hill Road Naugatuck, CT 06770 (203) 729-5237  800-243-5350  FAX (203) 729-5230

NFPA HMIS Health-1 Fire-0 Reac-2 Health-1 Fire-0 Reac-2

DATE OF ISSUE-5/25/00 I. IDENTIFICATION AND EMERGENCY INFORMATION

PRODUCT NAME: CLIDOX-S® BASE

PRODUCT CODE: 961

CHEMICAL NAME: MIXTURE

CAS NUMBER: N/A

PRODUCT APPEARANCE AND ODOR: LIGHT YELLOW CLEAR LIQUID - SLIGHT ODOR

EMERGENCY TELEPHONE NUMBERS: FOR CHEMICAL EMERGENCY CHEMTREC 1-800-424-9300 IN DISTRICT OF COLUMBIA COLLECT 483-7616 OUTSIDE THE CONTINENTAL U.S. COLLECT (202) 483-7616

II. COMPONENTS AND HAZARD INFORMATION

COMPONENTS CAS NO. OF APPROXIMATE COMPONENTS CONCENTRATION SODIUM CHLORITE 7758-19-2 0.85%

III. EMERGENCY AND FIRST AID PROCEDURES

EYE CONTACT FLUSH WITH WATER FOR AT LEAST 15 MINUTES- CONTACT PHYSICIAN

SKIN CONTACT WASH WITH SOAP & WATER FOR AT LEAST 15 MINUTES- REMOVE CONTAMINATED CLOTHING

INHALATION MOVE TO FRESH AIR. CONSULT A PHYSICIAN IF IRRITATION OF RESPIRATORY PASSAGES OCCUR

INGESTION DO NOT INDUCE VOMITING! DRINK LARGE QUANTITIES OF WATER. SEEK MEDICAL ATTENTION. DO NOT GIVE ANYTHING BY MOUTH IF THE PERSON IS UNCONSCIOUS OR HAVING SEIZURES. IV. FIRE AND EXPLOSION DATA

HANDLING PRECAUTIONS: KEEP CONTAINER COOL BY SPRAYING WITH WATER IF EXPOSED TO FIRE - EXTINGUISH WITH WATER EXTINGUISHING MEDIA AND FIRE KEEP CONTAINER COOL BY SPRAYING FIGHTING PROCEDURES: WITH WATER IF EXPOSED TO FIRE - EXTINGUISH WITH WATER

CLIDOX-S® BASE PAGE 1 OF 4 MATERIAL SAFETY DATA SHEET Pharmacal Research Laboratories Inc.  33 Great Hill Road Naugatuck, CT 06770 (203) 729-5237  800-243-5350  FAX (203) 729-5230

DECOMPOSITION PRODUCTS UNDER MAY REACT WITH COMBUSTIBLE FIRE CONDITIONS: SUBSTANCE CREATING FIRE OR EXPLOSION HAZARD “EMPTY” CONTAINER WARNINGS RINSE THOROUGHLY WITH WATER - DISPOSE OF CONTAINER IN CONFORMANCE WITH FEDERAL STATE AND LOCAL REGULATIONS

V. HEALTH AND HAZARD INFORMATION

VARIABILITY AMONG INDIVIDUALS: NONE KNOWN EFFECTS OF OVEREXPOSURE: INHALATION: IRRITATING (SIGNS AND SYMPTOMS OF EXPOSURE SKIN: IRRITATING INGESTION: TOXIC NATURE OF HAZARD AND TOXICITY INFORMATION: INHALATION: IRRITATING SKIN: IRRITATING INGESTION: ORAL LD 50 > 5.0 g./kg.

VI. PHYSICAL DATA THE FOLLOWING DATA ARE APPROXIMATE OR TYPICAL VALUES AND SHOULD NOT BE USED FOR PRECISE DESIGN PURPOSES. BOILING POINT 100oC SPECIFIC GRAVITY 1.01 pH 11.5 PERCENT VOLATILE BY VOLUME 91.5%

SOLUBILITY IN WATER @ 1 ATM AND 25C COMPLETE

VII. REACTIVITY

AVOID CONTACT WITH COMBUSTIBLE OR ACIDIC SUBSTANCES - WILL RELEASE CHLORINE DIOXIDE

VIII. SPILL OR LEAK PROCEDURES

STEPS TO BE TAKEN IN CASE MATERIAL IS RELEASED OR SPILLED: DO NOT ABSORB IN COMBUSTIBLE MATERIALS - DO NOT REPACK -CONTAIN SPILLED MATERIAL IN SUITABLE CONTAINERS OR HOLDING AREA. DISPOSE INTO

TREATMENT SYSTEM IN ACCORDANCE WITH FEDERAL, STATE, AND LOCAL LAWS.

IX. PROTECTION AND PRECAUTIONS

VENTILATION: GOOD VENTILATION

RESPIRATORY PROTECTION: NIOSH PERMISSIBLE RESPIRATORY PROTECTION IF THERE IS REASONABLE POSSIBILITY OF EXPOSURE PROTECTIVE GLOVES: LATEX OR VINYL GLOVES

EYE PROTECTION: CHEMICAL SPLASH GOGGLES

OTHER PROTECTIVE EQUIPMENT: APRON

WORK PRACTICES / SEE SECTION VII ENGINEERING CONTROL: PERSONAL HYGIENE: WASH AFTER HANDLING - CLEAN ANY CONTAMINATED CLOTHING BEFORE REUSING

X. TRANSPORTATION INFORMATION

TRANSPORTATION INCIDENT CLASSIFIED AS NON-HAZARDOUS INFORMATION:

DOT IDENTIFICATION NUMBER N/A

SHIPPING DESCRIPTION DISINFECTANT, NOI, ITEM # 57100, SUB 3

THE INFORMATION AND RECOMMENDATIONS CONTAINED HEREIN ARE, TO THE BEST OF PHARMACAL’S KNOWLEDGE AND BELIEF, ACCURATE AND RELIABLE AS OF THE DATE ISSUED. PHARMACAL DOES NOT WARRANT OR GUARANTEE THEIR ACCURACY OR RELIABILITY, AND PHARMACAL SHALL NOT BE LIABLE FOR ANY LOSS OR DAMAGE ARISING OUT OF THERE USE THEREOF.

THE INFORMATION AND RECOMMENDATIONS ARE OFFERED FOR THE USER’S CONSIDERATION AND EXAMINATION, AND IT IS THE USER’S RESPONSIBILITY TO SATISFY ITSELF THAT THEY ARE SUITABLE AND COMPLETE FOR ITS PARTICULAR USE.

THE HAZARDOUS MATERIALS IDENTIFICATION SYSTEM (HMIS) AND NATIONAL FIRE PROTECTION ASSOCIATION RATINGS HAVE BEEN INCLUDED BY PHARMACAL RESEARCH LABORATORIES INC. IN ORDER TO PROVIDE ADDITIONAL HEALTH AND HAZARD INFORMATION. THE RATINGS RECOMMENDED ARE BASED UPON CRITERIA SUPPLIED BY THE DEVELOPERS OF THESE RATING SYSTEMS, TOGETHER WITH PHARMACAL’S INTERPRETATION OF THE AVAILABLE DATA.

CLIDOX-S® BASE PAGE 4 OF 4